Urispas (Flavoxate Hydrochloride) - Summary

URISPAS SUMMARY

URISPAS^®
brand of
flavoxate HCl
mg tablets

URISPAS^® (flavoxate HCl) tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.

URISPAS^® (flavoxate HCl) is indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis. URISPAS^® is not indicated for definitive treatment, but is compatible with drugs used for the treatment of urinary tract infections.

URISPAS NEWS HIGHLIGHTS

Published Studies Related to Urispas (Flavoxate)

[Clinical evaluation of supplemental administration of flavoxate hydrochloride in benign prostatic hyperplasia patients with nocturia resistant to an alpha1-adrenoceptor blocker] [2008.03]

Conformational evaluation and detailed 1H and 13C NMR assignments of flavoxate, a urinary tract antispasmodic agent. [2006.05.03]

more>>

Clinical Trials Related to Urispas (Flavoxate)

Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP) [Recruiting]

more>>